vindesine has been researched along with Neoplasms, Pleural in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, E; Gralla, R; Kelsen, D; Martini, N | 1 |
| Kimura, H; Yamaguchi, Y | 1 |
| Miyazawa, N; Yokoi, K | 1 |
| Bross, KJ; Fiebig, HH; Herrmann, F; Licht, T; Lübbert, M; Martens, C; Mertelsmann, R | 1 |
| Airoma, G; Bianco, AR; Gridelli, C; Incoronato, P; Palazzolo, G; Pepe, R; Rossi, A | 1 |
| Lafitte, JJ; Lefebvre, J; Marquette, CH; Stach, B; Tonnel, AB; Vantyghem, MC | 1 |
| Boutin, C; Brambilla, C; Dabouis, G; Guérin, JC; Irisson, M; Jeannin, L; Le Caer, H; Paramelle, B; Roegel, E; Viallat, JR | 1 |
1 trial(s) available for vindesine and Neoplasms, Pleural
| Article | Year |
|---|---|
Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diaphragm; Female; Humans; Immunotherapy, Adoptive; Interleukin-2; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Pleural Neoplasms; Prognosis; Vindesine | 1995 |
6 other study(ies) available for vindesine and Neoplasms, Pleural
| Article | Year |
|---|---|
Vindesine in the treatment of malignant mesothelioma: a phase II study.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Male; Mesothelioma; Middle Aged; Pericardium; Peritoneal Neoplasms; Pleural Neoplasms; Vinblastine; Vindesine | 1983 |
Pleuropneumonectomy and postoperative adjuvant chemotherapy for carcinomatous pleuritis in primary lung cancer: a case report of long-term survival.
Topics: Adenocarcinoma, Papillary; Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Pleura; Pleural Effusion, Malignant; Pleural Neoplasms; Pleurisy; Pneumonectomy; Survival Rate; Vindesine | 1996 |
Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Mesothelioma; Pleural Neoplasms; Recombinant Proteins; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Verapamil; Vindesine | 1995 |
Mitomycin C and vindesine: an ineffective combination chemotherapy in the treatment of malignant pleural mesothelioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Male; Mesothelioma; Middle Aged; Mitomycin; Pleural Neoplasms; Treatment Outcome; Vindesine | 1992 |
[Adenocarcinomatous pleural lesion associated with hypoglycemia].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Hydrocortisone; Hypoglycemia; Male; Middle Aged; Mitomycins; Paraneoplastic Syndromes; Pleural Neoplasms; Vindesine | 1992 |
Phase II trial of vindesine in malignant pleural mesothelioma.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Vindesine | 1987 |